Core Insights - INNO Holdings Inc. has entered into a non-binding Memorandum of Understanding (MoU) with Megabyte Solutions Limited to form a strategic partnership focused on deploying Web3 technology in its cross-border B2B marketplace platform [1][2][3] - The collaboration aims to enhance the platform's global transactions by integrating blockchain-based logistics and supply chain management solutions, improving privacy, convenience, efficiency, and security [2][3] - The CEO of INNO emphasized that this partnership represents a pivotal step in the company's future development, aiming to address challenges in cross-border e-commerce and trade [3] Company Overview - INNO Holdings Inc. is a trade-focused electronic products trading company that is also involved in building technology, aiming to revolutionize the construction industry with proprietary cold-formed steel framing and AI-driven design [4] - The company is expanding its sales and distribution network in electronic product trading, seeking to create greater commercial value for its business partners and enhance its own enterprise value [4]

Core Insights - Crane Harbor Acquisition Corp. and Xanadu Quantum Technologies Inc. are moving forward with a proposed business combination, with an expected pro forma enterprise value of approximately US$3.1 billion and a pro forma market capitalization of US$3.6 billion [1][2] Company Overview - Xanadu Quantum Technologies, founded in 2016, is a leader in photonic quantum computing technology, operating at room temperature and offering the world's first networked, modular, and scalable quantum computer through its Aurora system [3] - Xanadu achieved quantum supremacy in 2022 with its 216-qubit Borealis system, marking a significant milestone in quantum computing [3] Financial Aspects - The combined entity, Xanadu Quantum Technologies Limited, is expected to be capitalized with approximately US$500 million in gross proceeds, including US$225 million from Crane Harbor's trust account and US$275 million from strategic and institutional investors through a PIPE investment [2] - The PIPE investment exceeds the minimum cash required to close the transaction under the business combination agreement [2] Strategic Positioning - The business combination positions Xanadu to become the first and only publicly traded pure-play photonic quantum computing company, leveraging photonics for various applications including quantum networking, sensing, and secure communications [4] - Xanadu is also a leader in quantum software through its PennyLane platform, which is widely implemented across major quantum computer providers [4] Regulatory and Transaction Details - The completion of the proposed transaction is subject to customary closing conditions, including shareholder approval and stock exchange listing [5] - The business combination is expected to close by the end of the first quarter of 2026 [5]

Core Viewpoint - ProMIS Neurosciences Inc. has announced a one-for-twenty-five reverse stock split to comply with Nasdaq listing requirements and aims to increase the market price of its common shares [1][11]. Group 1: Reverse Stock Split Details - The reverse stock split will take effect at 12:01 a.m. Eastern Time on November 28, 2025, with shares trading on a split-adjusted basis from that date [2]. - The number of outstanding common shares will decrease from approximately 53,811,110 shares to about 2,152,444 shares [3]. - Proportional adjustments will be made to equity incentive plans, stock options, and outstanding warrants in accordance with the reverse stock split [4]. Group 2: Compliance with Nasdaq - ProMIS received a deficiency letter from Nasdaq on January 8, 2025, indicating that its common shares had not maintained the minimum required closing bid price of at least $1.00 [8]. - The company was granted an additional 180-day compliance period until December 29, 2025, to regain compliance with the Bid Price Rule [10]. - The reverse stock split is part of the company's strategy to cure the deficiency and meet Nasdaq's listing standards [11]. Group 3: Shareholder Information - No fractional shares will be issued; shareholders entitled to fractional shares will receive cash instead [5]. - Stockholders with shares held in book-entry form or through a bank or broker will see the effects of the reverse stock split reflected in their accounts without needing to take action [6]. Group 4: Company Overview - ProMIS Neurosciences is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative disorders, including Alzheimer's disease [13]. - The company utilizes its proprietary target discovery engine, EpiSelect™, to identify novel targets associated with misfolded proteins [13].

Core Viewpoint - Condor Energies Inc. has successfully drilled its first horizontal well, Andakli-23, in Uzbekistan, achieving significant production increases and planning further drilling activities in the region [1][5]. Group 1: Well Performance and Production - The Andakli-23 horizontal well reached a total depth of 3,775 meters, including 1,007 meters of open hole horizontal section, and has increased average daily production to 11,844 barrels of oil equivalent per day (boepd) over the past three days [1][2]. - The well is expected to be placed on production in December 2025 after flow testing [2]. - Recent workovers in the North Syuzma field have also shown strong gas flow, with production rates reaching 9,978 boepd in the third quarter of 2025 [6]. Group 2: Technical Insights and Future Plans - The drilling operations included a vertical pilot hole that evaluated the prospectivity of the Jurassic clastics, identifying fair to good reservoir quality with estimated porosities of 9 to 13% [3]. - The company plans to drill up to 12 new wells in 2026, with the next horizontal well targeting a different carbonate reservoir [5][6]. - The successful introduction of new technologies and techniques during the drilling of A-23 is expected to enhance future production capabilities [5].

Hong Kong, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Abits Group Inc (the “Company”) (NASDAQ: ABTS), a digital data center operator specializing in bitcoin self-mining operations, today announced the results of its 2025 Annual Meeting of Shareholders held on November 21, 2025 in Hong Kong. At the meeting, the shareholders: ●Elected Conglin (Forrest) Deng, Lionel Choong Khuat Leok, Tao Xu, Chuan Zhan, and Yanyan Sun to its Board of Directors; and ●Ratified the appointment of Audit Alliance LLP as the Company’s inde ...

EL MONTE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Larry Wu, it’s Founder and Chief Executive Officer, and Erica Wei, its Chief Financial Officer, will conduct one-on-one meetings with investors at the 2025 UBS Global Technology and AI Conference, being held from December 1 through December 4 in Scottsdale, Arizona. To schedule a m ...

TEL AVIV, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that co-founder and CEO Adi Mor, PhD, will participate in Oppenheimer's Movers in Rare Disease Summit on Thursday, December 11, 2025, at the Sofitel Hotel in New York City. The invitation-only Rare Disease Summit will feature a day of panels, presentations and 1 ...

Core Insights - Ceribell, Inc. has received FDA 510(k) clearance for its Clarity algorithm, making it the first and only AI-powered EEG technology for detecting electrographic seizures in patients from pre-term neonates to adults [1][3] Group 1: Product and Technology - The Ceribell System combines proprietary algorithms with specialized hardware to enable real-time detection of non-convulsive seizures in neonatal patients, facilitating rapid diagnosis and treatment [3] - The FDA clearance was supported by EEG data from over 700 patients, representing the largest validation dataset for a neonatal seizure detection system [3] Group 2: Market Need and Impact - Early detection of seizures is critical in neonatal care, with approximately 9% of NICU patients diagnosed with seizures, while up to 90% may go undetected without EEG monitoring [2] - High-risk newborns who experience prolonged seizures have an 8-fold increased risk of poor outcomes, including mortality and long-term disability [2] - Recent guidelines recommend continuous EEG monitoring for neonates at high risk for seizures, highlighting the need for timely intervention [2] Group 3: Company Vision and Leadership - The CEO of Ceribell emphasized the importance of timely and accessible seizure detection for newborns, aiming to reduce delays and improve outcomes [4] - The Medical Director of Neonatal ECMO at Stanford Children's Hospital noted the lack of 24/7 EEG access in many NICUs, underscoring the need for faster, more accessible tools for evaluating brain activity [4] Group 4: Company Overview - Ceribell is focused on transforming the diagnosis and management of serious neurological conditions, with its system currently utilized in intensive care units and emergency rooms across the U.S. [7] - The company is headquartered in Sunnyvale, California, and aims to address unmet needs in acute care settings through its innovative EEG platform [7]

VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- American Hotel Income Properties REIT LP (“AHIP”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB. V), today announced that it has completed its normal course issuer bid (the “NCIB”) and related automatic securities purchase plan (“ASPP”) that commenced on December 30, 2024. AHIP has purchased a total of 7,521,189 units of AHIP under the NCIB and ASPP, representing approximately 10% of its public float at the commencement of the NCIB. The units were purch ...

The company’s AI Event Trading Desk prices and trades Polymarket prediction markets with EBZT capital in search of scalable, hedged trading profitsJacksonville, FL, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Everything Blockchain Inc. (OTC: EBZT), a public AI development lab for digital asset markets, today announced the launch of an AI Event Trading Desk that uses company capital to price and trade prediction markets on Polymarket. The desk is built to turn mispriced odds on real world events, including elections, ...